Skip to content

Observation on the clinical efficacy of Sangma Apricot and Shellfish Soup combined with Tuina in AECOPD patients Research Program

Observation on the clinical efficacy of Sangma Apricot and Shellfish Soup combined with Tuina in AECOPD patients Research Program

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001564
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AECOPD

Interventions

control subjects1:Conventional Western medicine plus massage
control subjects2:Western medicine conventional treatment plus Chinese medicine
treatment group:Western medicine conventional treatment plus Chinese medicine combined with massage

Sponsors

No. 1130 Dongshijiahui Road Hongkou District Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1Meet the diagnosis of AECOPD in Western medicine and the diagnostic criteria of phlegm-heat congestion of the lungs syndrome in Chinese medicine; 2Age = 50 years old age = 80 years old gender is not limited; 3 Patients who satisfy the moderate degree of AECOPD in the Roman classification ; 4Understanding agreeing to participate in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1Patients with a history of participation in other clinical drug trials within the past 90 days. 2Patients with chronic cough and wheezing caused by respiratory diseases such as bronchiectasis or bronchial asthma. 3Patients with known allergy to any component of the Sangma Xingbei Decoction. 4Patients with concurrent major organ dysfunction, primary diseases of the hematopoietic or endocrine systems. 5Pregnant or lactating women, and those with osteoporosis. 6Individuals with evident disabilities or those legally recognized as disabled. 7Suspected history of drug or alcohol abuse, or patients whose condition is too complex and may interfere with the diagnosis of the target disease. 8Any other conditions judged by the investigator to render the patient unsuitable for enrollment in this treatment.

Design outcomes

Primary

MeasureTime frame
Chinese Medicine Symptom Score;

Secondary

MeasureTime frame
respiratory muscle strength;COPD Assessment Test Score;Cough Severity Visual Analogue Scale Score;sputum;sputum viscosity;spirometry;6-Minute Walk Distance;C-Reactive Protein;White Blood Cell;

Countries

China

Contacts

Public ContactZhen-wei Wang Liang-shan Liu

Yueyang Hospital Shanghai University of Traditional Chinese Medicine

lls6232023@163.com18918757762

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026